Does USTEKINUMAB Cause Flushing? 213 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 213 reports of Flushing have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.3% of all adverse event reports for USTEKINUMAB.
213
Reports of Flushing with USTEKINUMAB
0.3%
of all USTEKINUMAB reports
0
Deaths
14
Hospitalizations
How Dangerous Is Flushing From USTEKINUMAB?
Of the 213 reports, 14 (6.6%) required hospitalization, and 9 (4.2%) were considered life-threatening.
Is Flushing Listed in the Official Label?
Yes, Flushing is listed as a known adverse reaction in the official FDA drug label for USTEKINUMAB.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Flushing?
DIMETHYL (10,681)
TREPROSTINIL (3,166)
TECFIDERA (2,385)
AMBRISENTAN (1,741)
DALFAMPRIDINE (1,605)
DIROXIMEL (1,518)
INFLIXIMAB (1,488)
PACLITAXEL (1,397)
GLATIRAMER (1,291)
EPOPROSTENOL (1,256)
Which USTEKINUMAB Alternatives Have Lower Flushing Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE